Efficacy of Oral Mucoadhesive N-Acetylcysteine Tablets in Treatment of Recurrent Aphthous Stomatitis: A Randomized Double-Blind, Placebo-Controlled Clinical Trial.

Objectives: This study aimed to assess the efficacy of oral mucoadhesive N-acetylcysteine (NAC) tablets for treatment of recurrent aphthous stomatitis (RAS). Materials and Methods: Forty-nine patients with RAS were randomized to receive mucoadhesive NAC tablets (n=25) or placebo (n=24). Tablets were prescribed three times a day for 7 days in each group. Pain intensity was evaluated with visual analog scale (VAS) three times a day from day 1 to day 7. Also, patients were clinically examined on days 0 (before entering the study), 3, 5, and 7 using a metal caliper to measure the diameter of the lesions. The data were statistically analyzed and P<0.05 was considered statistically significant. Results: Regarding the VAS score, all participants in the treatment group showed complete recovery on day 7 (P<0.01). Also, the diameter of the lesions was significantly smaller in the treatment group than the placebo group at the end of the study (P<0.001). Conclusion: The results of this clinical trial showed for the first time that mucoadhesive NAC tablets can significantly decrease pain and the diameter of RAS lesions without any systemic complications.

Salivary Vascular Endothelial Growth Factor and Epidermal Growth Factor Levels in Patients with Recurrent Aphthous Stomatitis: a Meta-Analysis.

Recurrent aphthous stomatitis (RAS) has been identified as a common oral lesion with an unknown pathogenesis. Various studies have been conducted to show the important role of two factors named epidermal growth factor (EGF) and vascular endothelial growth factor (VEGF) in RAS, but certain results have not been achieved. The present meta-analysis was conducted to evaluate the salivary levels of EGF and VEGF in patients with RAS. For this purpose, the related articles in the Web of Science, PubMed, Embase, ProQuest and Scopus databases until January 2022 were searched and their abstracts were studied. Google scholar and scientific information database were also searched for articles in Persian. The searches were completed by the medical subject heading terms considering "recurrent aphthous stomatitis" and "saliva" in combination with "EGF" or "VEGF" keywords. All case control studies that evaluated the salivary levels of EGF and VEGF in patients with RAS were included in this study. To evaluate statistical heterogeneity between the studies, Cochrane Q and I2 tests were adopted. The extracted data then were used in the analysis process based on comprehensive meta-analysis software. Originally, 619 articles were considered, of which 7 articles were selected. According to this meta-analysis, salivary EGF and VEGF levels were significantly lower in the active and remission period of RAS than in healthy individuals (pValue< 0.05). In addition, salivary levels of these factors were significantly lower in the active stage of RAS than in the healing phase. This review study suggests that decreasing of salivary EGF and VEGF levels have significant role in the development of RAS.

Eficacia del bórax en el tratamiento de la estomatitis aftosa

Fundamento: la estomatitis aftosa es una enfermedad crónica caracterizada por la ulceración de la mucosa bucal no queratinizada, que se presenta de forma aguda y dolorosa. Objetivo: evaluar la eficacia del bórax en el tratamiento de la estomatitis aftosa. Métodos: se realizó un estudio analítico, longitudinal prospectivo, en el Departamento de Estomatología del Policlínico Norte, Ángel del Castillo Agramonte, del municipio de Florida, en el período comprendido de diciembre del 2019 hasta abril del 2021. El universo estuvo constituido por 139 pacientes, y la muestra quedó conformada por 70 pacientes seleccionados por un método aleatorio simple. La misma quedó dividida en dos grupos: uno de estudio y otro de control a los que se le aplicó un tratamiento homeopático con bórax y un tratamiento convencional, respectivamente. Resultados: el rango de edad más afectado fue el de 21- 30 años, y el sexo femenino fue el más representado; los labios constituyeron el sitio de mayor afectación y prevaleció la estomatitis aftosa en su forma menor. En cada visita de control se observó una mejor evolución del dolor, el ardor y la cicatrización de las lesiones con el tratamiento homeopático, que con el convencional; se observó una efectividad de un 100 % en los pacientes tratados con bórax y la mayoría de los pacientes se mostró satisfecha con el tratamiento homeopático recibido. Conclusiones: el bórax resulta eficaz para el tratamiento de la estomatitis aftosa.

Background: aphthous stomatitis is a chronic disease characterized by the non-keratinized oral mucosa ulceration, which presents acutely and painfully. Objective: to evaluate the efficacy of borax in the aphthous stomatitis treatment. Methods: an analytical, longitudinal prospective study was carried out in the North Polyclinic Stomatology Department, Ángel del Castillo Agramonte, in the Florida municipality, from December 2019 to April 2021. 139 patients were studied and the sample was made up of 70 patients selected by a simple random method. It was divided into two groups: a study group and a control group to which a homeopathic treatment with borax and a conventional treatment were applied, respectively. Results: the most affected age range was 21-30 years old, and the female sex was the most represented; the lips were the most affected site and aphthous stomatitis prevailed in its minor form. At each control visit, a better evolution of pain, burning, and healing of the lesions was observed with the homeopathic treatment than with the conventional one; an effectiveness of 100% was observed in the patients treated with borax and the majority of the patients were satisfied with the homeopathic treatment received. Conclusions: borax is effective for the treatment of aphthous stomatitis.

Tratamiento con radiación láser de baja potencia en pacientes con estomatitis aftosa recurrente

Fundamento entre las urgencias periodontales que requieren atención inmediata está la estomatitis aftosa recurrente, debido a las molestias o complicaciones que ocasiona al paciente. El empleo de la radiación láser de baja potencia puede resultar efectivo en el tratamiento de esta entidad. Objetivo determinar el efecto terapéutico del tratamiento con radiación láser de baja potencia en pacientes con diagnóstico de estomatitis aftosa recurrente. Métodos estudio descriptivo, transversal, realizado en el periodo mayo/2019-mayo/2021, en el servicio estomatológico del policlínico Dr. Enrique Barnet, del municipio de Lajas, provincia de Cienfuegos, que incluyó a 46 pacientes con diagnóstico de estomatitis aftosa recurrente. Se empleó el análisis de documentos, la observación y el cuestionario; además del examen bucal como método diagnóstico. Los pacientes recibieron tratamiento con radiación láser de baja potencia. Se aplicó el programa EPIDAT 3.1 para el procesamiento estadístico de los datos. Resultados predominó el sexo femenino, la edad entre 19-34 años, así como las úlceras aftosas menores. Las lesiones se localizaron principalmente en labio. El 97,83 % de los pacientes refirió remisión de la lesión al quinto día de tratamiento. Todos los pacientes tratados evolucionaron favorablemente hacia la cicatrización. Solo un paciente presentó reacciones adversas. Conclusiones los resultados permitieron constatar los beneficios terapéuticos de la terapia con láser de baja potencia en el tratamiento de la estomatitis aftosa recurrente.

Background among the periodontal emergencies that require immediate attention is the RAS, due to the inconvenience or complications that it causes to the patient. The use of low power laser radiation can be effective in the treatment of this entity. Objective to determine the therapeutic effect of treatment with low-power laser radiation in patients diagnosed with recurrent aphthous stomatitis. Methods descriptive, cross-sectional study, carried out from May/2019 to May/2021, in the Dr. Enrique Barnet polyclinic's dental service, in Lajas municipality, Cienfuegos province, which included 46 patients diagnosed with recurrent aphthous stomatitis. Document analysis, observation and questionnaire were used; in addition to the oral examination as a diagnostic method. Patients received treatment with low-power laser radiation. The EPIDAT 3.1 program was applied for the statistical data processing. Results the female sex predominated, the age between 19-34 years, as well as minor aphthous ulcers. The lesions were located mainly on the lip. 97.83% of the patients reported remission of the lesion on the fifth day of treatment. All treated patients evolved favorably towards healing. Only one patient presented adverse reactions. Conclusions the results allowed us to verify the therapeutic benefits of low power laser therapy in the treatment of recurrent aphthous stomatitis.

Efectividad del Tysuacril en la estomatitis aftosa / Effectiveness of Tysuacril in aphthous stomatitis

RESUMEN Introducción: el Tisuacryl es un biomaterial empleado en la cirugía general y bucal, así como en el tratamiento de la estomatitis aftosa, considerada un proceso multifactorial y actualmente la enfermedad ulcerosa más común de la cavidad oral. Objetivo: determinar la efectividad del Tisuacryl con respecto a la terapia convencional en el tratamiento de la estomatitis aftosa en Consolación del Sur, Pinar del Río, en el período comprendido entre septiembre 2018 y marzo 2020. Métodos: se realizó un estudio observacional analítico de casos y controles a 90 pacientes con estomatitis aftosa en Consolación del Sur, Pinar del Río, en el período comprendido entre septiembre 2018 y marzo 2020. La información se obtuvo de las historias clínicas individuales de Periodoncia al obtener el consentimiento oral y escrito de los pacientes o sus tutores. Los resultados se obtuvieron por análisis estadístico que incluyó el porciento y la prueba no paramétrica de Cochran Q. Resultados: predominó el sexo femenino y el grupo etario de 10 a 19 años para el 46,7 % en grupo estudio y el 42,2 % en grupo control; la disminución del dolor y la cicatrización iniciaron en el mayor número de pacientes a las 72 horas de tratamiento con Tisuacryl para el 91,1 % y el 55,6 % respectivamente; a los cinco días de aplicación del medicamento la totalidad de ellos estaban asintomáticos y casi todas las aftas bucales cicatrizadas. Conclusiones: las lesiones aftosas en la cavidad bucal evolucionaron satisfactoriamente con la aplicación del Tisuacryl al ser esta una alternativa efectiva de tratamiento en comparación con la terapia convencional.

ABSTRACT Introduction: Tisuacryl is a biomaterial used in general and oral surgery, as well as in the treatment of aphthous stomatitis, considered a multifactorial process and currently the most common ulcerative disease of the oral cavity. Objective: to determine the effectiveness of Tisuacryl with respect to conventional therapy in the treatment of aphthous stomatitis in Consolación del Sur, Pinar del Río, in the period from September 2018 to March 2020. Methods: an analytical observational case-control study was conducted on 90 patients with aphthous stomatitis in Consolación del Sur, Pinar del Río, in the period from September 2018 to March 2020. Information was obtained from individual Periodontics medical records by obtaining oral and written consent from patients or their guardians. Results were obtained by statistical analysis including percent and Cochran Q nonparametric test. Results: female sex and age group from 10 to 19 years old predominated for 46,7 % in the study group and 42,2 % in the control group; the decrease of pain and healing started in most patients 72 hours after treatment with Tisuacryl for 91,1 % and 55,6 % respectively; being five days after application of the drug all of them asymptomatic and almost all the oral aphthae healed. Conclusions: aphthous lesions in the oral cavity evolved satisfactorily with the application of Tisuacryl being an effective treatment alternative in comparison with conventional therapy.

Una mirada al tratamiento actual de la estomatitis aftosa recurrente. Revisión de la literatura / A look at the current management of recurrent aphthous stomatitis: scoping review

Resumen La estomatitis aftosa recurrente (EAR) es una patología ulcerativa crónica idiopática, que, aunque no llega a comprometer la vida de los pacientes, si puede desmejorar su calidad de vida. Presenta una alta incidencia en la población con un alto porcentaje de recurrencia. Atendiendo a su importancia, el objetivo de esta revisión es brindar una actualización respecto a las terapias farmacológicas y con láser para el manejo de la estomatitis aftosa recurrente. Se realizó una búsqueda bibliográfica en las bases de datos PubMed, Science Direct, EBSCO HOST y LILACS desde enero de 2010 a octubre de 2020, identificando publicaciones en inglés y español. Los artículos que fueron incluidos debían estar relacionadas con la estomatitis aftosa y su tratamiento, enfocándose en el manejo farmacológico o con láser. La estrategia de búsqueda arrojó 4536 citas bibliográficas, de las cuales fueron incluidas 19 en esta presente revisión. La mayoría de los estudios fueron ensayos clínicos aleatorizados donde la población objeto fueron adultos que demostraron el uso de antiinflamatorios, inmunomoduladores, anticuerpos monoclonales, antisépticos, anestésicos, entre otros, para el manejo de la estomatitis aftosa recurrente. De los artículos analizados se pudo concluir que la terapia farmacológica debe ser instaurada de manera particular, de acuerdo a la clínica y antecedentes del paciente. Los fármacos de primera elección son de uso tópico, reservando los de uso sistémico para casos moderados o severos y para pacientes con tratamiento refractarios, asimismo, las recomendaciones coadyuvantes como alimentación e higiene pueden ayudar a la resolución de la enfermedad. La terapia láser surge como alternativa de tratamiento con bajo riesgo y buenos resultados para la EAR.

Abstract Recurrent Aphthous Stomatitis (RAS) is an idiopathic chronic ulcerative pathology. Although it does not compromise the life of the patients, it can impair their quality of life. It presents a high incidence in the population and a high percentage of recurrence. In view of its importance, the aim of this review is to provide an update on pharmacological and laser therapies that are being implemented for the management of RAS. A bibliographic search of literature that was published between January 2010 and October 2020 was performed in PubMed, Science Direct, EBSCOhost, and LILACS databases, identifying publications in English and Spanish languages. The articles that were included had to be related to aphthous stomatitis and its treatment, focusing on pharmacological or laser management. 4536 bibliographic citations were found and 19 of them were included in this review. Most of the studies were randomized clinical trials in which the target population were adults that reported the use of anti-inflammatory drugs, immunomodulators, monoclonal antibodies, antiseptics, anesthetics, among others for the treatment of recurrent aphthous stomatitis. From the articles analyzed, it was possible to conclude that pharmacological therapy should be established in a particular way according to the patient's symptoms and medical record. The first-choice drugs are of topical use, reserving those of systemic use for moderate or severe cases and for patients with refractory treatment. Likewise, adjuvant recommendations such as nutrition and hygiene can help in the resolution of the disease. Laser therapy emerges as an alternative treatment with low risk and positive results for recurrent aphthous stomatitis.

Periodic fever, aphthous stomatitis, pharyngitis and cervical adenitis syndrome in children: a brief literature review / Síndrome da febre periódica, estomatite aftosa, faringite e adenite em crianças: uma breve revisão de literatura

ABSTRACT Objective: To describe clinical, diagnostic and therapeutic characteristics of the periodic fever, aphthous stomatitis, pharyngitis and cervical adenitis (PFAPA) syndrome. Data source: Literature review in the PubMed database by using specific descriptors to identify all articles published in the English language in the last three years; 38 articles were found. After performing selection of titles and abstract analysis, 13 out of the 38 articles were fully read. Relevant studies found in the references of the reviewed articles were also included. Data synthesis: The PFAPA syndrome (Periodic Fever, Aphthous Stomatitis, Pharyngitis and cervical Adenitis) is a medical condition grouped among the periodic fever syndromes. The etiology is uncertain, but possibly multifactorial, and its symptoms are accompanied by recurrent febrile episodes although weight and height development are preserved. It is a self-limiting disease of benign course with remission of two to three years without significant interference in the patient's overall development. Treatment consists of three pillars: interruption of febrile episodes, increase in the interval between episodes, and remission. Conclusions: Despite several attempts to establish more sensitive and specific criteria, the diagnosis of PFAPA syndrome is still clinical and reached by exclusion, based on the modified Marshall's criteria. The most common pharmacological options for treatment include prednisolone and betamethasone; colchicine may be used as prophylaxis, and surgical treatment with tonsillectomy can be considered in selected cases.

RESUMO Objetivo: Descrever as características clínicas, diagnósticas e de tratamento da síndrome de febre periódica, estomatite aftosa, faringite e adenite (PFAPA). Fontes de dados: Revisão de literatura na base de dados PubMed, feita por meio de descritores específicos para identificar todos os artigos publicados em língua inglesa nos últimos três anos. Dos 38 artigos encontrados, foram encaminhados para leitura integral 13 publicações após seleção de títulos e análise de abstract. Estudos relevantes encontrados nas referências dos artigos revisados também foram incluídos. Síntese dos dados: A PFAPA é traduzida do inglês periodic fever, aphthous stomatitis, pharyngitis and cervical adenitis. Caracterizada por etiologia ainda incerta e possivelmente multifatorial, seus sintomas são acompanhados por episódios recorrentes de febre associados a um desenvolvimento pôndero-estatural preservado. É uma doença autolimitada de curso benigno, com remissão em dois a três anos, sem interferências significativas no desenvolvimento do paciente pediátrico. O tratamento consiste em três pilares: interrupção da crise febril, aumento do intervalo entre crises e remissão. Conclusões: Apesar de várias tentativas de estabelecer critérios atuais mais sensíveis e específicos, o diagnóstico da síndrome PFAPA ainda é clínico e de exclusão com base nos critérios de Marshall modificados. As opções farmacológicas mais utilizadas para o tratamento são a prednisolona e betametasona; colchicina pode ser utilizada como profilaxia e o tratamento cirúrgico com tonsilectomia pode ser considerado em casos selecionados.

Evaluación de la eficacia de la tintura de manzanilla al 20 % en la estomatitis aftosa / Evaluation of the efficacy of 20 % chamomile tincture in aphthous stomatitis

RESUMEN Fundamentación: En el tratamiento tradicional de la estomatitis aftosa no se incluye la tintura de manzanilla al 20 %, sin embargo, sus propiedades justifican su posible utilización. Objetivo: Evaluar la eficacia de la tintura de manzanilla al 20 % como alternativa de tratamiento en pacientes con estomatitis aftosa en la disminución de la intensidad del dolor. Metodología: Se realizó un estudio experimental abierto, controlado y aleatorizado en el municipio Sancti Spíritus entre septiembre de 2019 y marzo de 2021. Se seleccionaron 39 pacientes con estomatitis aftosa mayores de 12 años de edad; mediante asignación aleatoria, se conformaron 2 grupos al azar: 1 de estudio aplicando tintura de manzanilla al 20 % y otro de control utilizando triamcinolona al 0.1 %. La variable de resultado principal del estudio utilizada fue la eficacia. Resultados: Predominó el sexo femenino para ambos grupos. En el grupo estudio, la edad más representativa fue de 24 a 35 años (25 %) y en el grupo control predominaron las edades de 36 a 47 años (26.3 %). Al comparar la intensidad del dolor en los diferentes momentos de evolución no existieron diferencias significativas entre ambos grupos. Se observó un predominio de pacientes sin reacciones adversas, estas se presentaron en un número muy reducido, 1 paciente en cada grupo. Conclusiones: La tintura de manzanilla al 20 % como alternativa de tratamiento de los pacientes con estomatitis aftosa, resultó de eficacia similar a la triamcinolona al 0.1 %.

ABSTRACT Background: Traditional treatment of aphthous stomatitis does not include 20 % chamomile tincture, however its properties justify its possible use. Objective: To evaluate the efficacy of 20 % chamomile tincture as an alternative treatment in patients with aphthous stomatitis for the reduction of pain intensity. Methodology: An exposed, controlled and randomized experimental study was conducted in Sancti Spíritus municipality between September 2019 and March 2021. Thirty-nine patients with aphthous stomatitis older than 12 years of age were selected; by random assignment, 2 groups were randomly formed: 1 study group applying chamomile tincture at 20 % and another control group using triamcinolone at 0.1 %. Efficiency was the main outcome study variable. Results: Female sex predominated in both groups. In the study group, the most representative age was 24 to 35 years (25 %) in the control group the predominant age was 36 to 47 years (26.3 %). When comparing the pain intensity at different times of evolution there were no significant differences between the two groups. A patients' prevalence without adverse reactions was observed, these occurred in a very small number, 1 patient in each group. Conclusions: The efficacy of chamomile tincture at 20 %, as an alternative treatment for patients with aphthous stomatitis, was similar to that of triamcinolone at 0.1 %.

Imbalances of the oral microbiota in recurrent aphthous stomatitis: a systematic review / Desequilibrios de la microbiota oral en la estomatitis aftosa recurrente: revisión sistemática

The etiopathogenesis of recurrent aphthous stomatitis is still unknown, however, there are some studies that report a probable role of the presence of some microbial communities in the alteration of the oral microbiota. In this systematic review (PROSPERO registry # CRD42021259427), we evaluated whether imbalances in the oral microbiota are associated with recurrent aphthous stomatitis. From case-control studies we determined that bacterial diversity does not change notably in sick people, however these changes are evident in terms of relative abundance, such as the increase in the genus Prevotella and the decrease in the genus Streptococcus.

Aún se desconoce la etiopatogenia de la estomatitis aftosa, no obstante, existen algunos estudios que reportan un probable rol de la presencia de algunas comunidades microbianas en la alteración de la microbiota oral. En esta revisión sistemática (registro PROSPERO #CRD42021259427), evaluamos si los desequilibrios en la microbiota oral están asociadas con la estomatitis aftosa recurrente. A partir de estudios de casos y controles determinamos que la diversidad bacteriana no cambia notablemente en personas enfermas, sin embargo esos cambios son evidentes en términos de abundancia relativa como el aumento del género Prevotella y la disminución del género Streptococcus.

La tintura de manzanilla al 20 % como alternativa de tratamiento para la estomatitis aftosa / Chamomile tincture at 20 % as an alternative treatment for aphthous stomatitis

RESUMEN Fundamento: Las aftas son causa de consultas frecuentes entre las urgencias estomatológicas. La tintura de manzanilla, resulta muy efectiva por su propiedad analgésica, antiinflamatoria, protectora, reparadora de membrana y reepitelizante. Objetivo: Ilustrar los resultados de la tintura de manzanilla al 20 % como alternativa de tratamiento en una paciente con estomatitis aftosa Presentación de caso: Paciente de 66 años de edad, femenina, con antecedentes de salud, fumadora, sometida a estrés, que acudió a consulta por lesiones aftosas dolorosas en el borde lateral izquierdo y dorso de la lengua. Conclusiones: La paciente con estomatitis aftosa, tratada con tintura de manzanilla al 20 %, mostró moderación del dolor a los 3 días, evolución general satisfactoria y cicatrización de las lesiones a los 5 días de la primera aplicación.

ABSTRACT Background: Aphthous ulcers are a frequent cause of assistance at the stomatology emergencies. Chamomile tincture (Matricaria Chamomilla) is very effective due to its analgesic, anti-inflammatory, protective, membrane-repairing and re-epithelialising properties. Objective: To illustrate the results of chamomile tincture at 20 % as an alternative treatment in a patient with aphthous stomatitis. Case report: A 66-year-old female patient, with healthy backgrounds, smoker, under stress, who consulted because of painful aphthous lesions on the left lateral border and tongue dorsum. Conclusions: The patient with aphthous stomatitis, treated with chamomile tincture at 20 %, showed pain moderation after 3 days, satisfactory general evolution and healing of the lesions 5 days after the first application.

Quality of Life in Patients with Chronic Oral Mucosal Conditions: A Qualitative Research

ABSTRACT Objective: To use qualitative research methods to evaluate the experiences of patients with chronic oral diseases. Material and Methods: Purposive sampling was used to recruit patients from the Oral Medicine Unit of Kerman University Dental School. An experienced independent facilitator convened the focus groups and conducted individual interviews in a non-clinical setting. Focus groups were mixed regarding their gender, age, chronic oral mucosal condition, time since diagnosis, and severity. A total of 39 patients participated in the study, including patients with oral lichen planus, pemphigus, recurrent aphthous stomatitis and leukoplakia. Results: Analysis of the interviews revealed that patient views could be divided into the following themes: biopsychosocial issues, treatment limitations and side effects, unpredictability of the conditions and the potential for malignant transformation. Chronic oral mucosal conditions affected patients' daily lives in various areas, from physical health and functioning to concerns about their future. Conclusion: The oral medicine practitioner's role in treating patients with chronic oral mucosal diseases extended beyond active management and symptomatic relief to the management of all aspects of these conditions that affected their daily lives.

Serum vitamin B12 associated with vitamin D/25(OH)D in women with recurrent aphthous stomatitis / Vitamina B12 sérica asociada con vitamina D / 25 (OH) D en mujeres con estomatitis aftosa recurrente

Vitamin B12 and Vitamin D deficiency may contribute to recurrent aphthous stomatitis (RAS). Current studies have showed vitamin B12 to be associated with vitamin D in women, however no study has assessed vitamin B12 associated with vitamin D/25(OH)D in women with RAS. Objective: To investigate the association between serum vitamin B12 and vitamin D/25(OH)D in women with RAS. Materials and Methods: Fourty one women with RAS who meet the inclusion criteria participated in this study. The inclusion criteria were women with RAS without other oral diseases. The exclusions criteria were those who have systemic diseases, taking medications or smoked. All subjects underwent venupuncture to draw blood to quantify serum vitamin B12 and vitamin D/25(OH)D. The characteristic of subjects, severity of RAS, serum Vitamin B12 and Vitamin D/25(OH)D were collected and presented descriptively. The correlation between vitamin B12 and Vitamin D/25(OH)D was analyzed using Pearson correlation test with 95% confidence interval. This study was approved by Medical and Health Ethics Committe, Faculty of Medicine, Universitas Gadjah Mada, Yogyakarta, Indonesia. Results: All RAS subjects have normal mean value of serum Vitamin B12 (453.97+154.44pg/ml) and have low mean value of serum vitamin D/25(OH)D (10.79 +3.29ng/ml) categorized as vitamin D deficiency. The Pearson correlation test showed that there was a significant positive correlation between mean serum Vitamin B12 and Vitamin D/25(OH)D (r= 0.313, p<0.05). Conclusion: There is correlation between vitamin B12 and Vitamin D, and a low level of Vitamin D may contribute in RAS in women.

Antecedentes: la deficiencia de vitamina B12 y vitamina D puede contribuir a la estomatitis aftosa recurrente (EAR). Los estudios actuales han demostrado que la vitamina B12 está asociada con la vitamina D en mujeres, sin embargo, ningún estudio ha evaluado la vitamina B12 asociada con la vitamina D/25 (OH) D en mujeres con EAR. Objetivo: investigar la asociación entre la vitamina B12 y la vitamina D / 25 (OH) D sérica en mujeres con RAS. Material y Métodos: Cuarenta y una mujeres con RAS que cumplen con los criterios de inclusión participaron en este estudio. Los criterios de inclusión fueron mujeres con RAS y sin otras enfermedades orales. Los criterios de exclusión fueron aquellos que tenían enfermedades sistémicas, tomaban medicamentos o fumaban. Todos los sujetos se sometieron a una venupuntura para extraer sangre para cuantificar la vitamina B12 y la vitamina D/25 (OH) D en suero. Las características de los sujetos, la severidad del EAR, la concentración de vitamina B12 y la vitamina D/25 (OH) D sérica fueron recolectadas y presentadas descriptivamente. La correlación entre la vitamina B12 y la vitamina D/25 (OH) D se analizó mediante la prueba de correlación de Pearson con un intervalo de confianza del 95%. Este estudio fue aprobado por el Comité de Ética Médica y de Salud, Facultad de Medicina, Universitas Gadjah Mada, Yogyakarta, Indonesia. Resultado: Todos los sujetos con EAR tienen un valor medio normal de vitamina B12 sérica (453,97pg/ml + 154,44pg/ml) y un valor medio bajo de vitamina D sérica/25 (OH) D (10,79 ng/ml + 3,29ng/ml) clasificado como deficiencia de vitamina D. La prueba de correlación de Pearson mostró que había una correlación positiva significativa entre la vitamina B12 media y la vitamina D/25 (OH) D en suero r=0.313, p<0.05). Conclusión: Existe una correlación entre la vitamina B12 y la vitamina D, y un bajo nivel de vitamina D puede contribuir al RAS en las mujeres.

Síndrome PFAPA: Diagnóstico e Tratamento na Atenção Primária à Saúde / PFAPA Syndrome: Diagnosis and Treatment in Primary Health Care / Síndrome PFAPA: Diagnóstico y Tratamiento en la Atención Primaria a la Salud

Objetivo: Apresentar informações sobre o diagnóstico e tratamento da síndrome PFAPA na Atenção Primária à Saúde. Métodos: Revisão sistemática de literatura baseada na recomendação PRISMA e realizada nas bases de dados Scielo, Lilacs, Medline, IBECS e PubMed, incluindo estudos publicados no período de 2004 a 2018, além da consulta a outros documentos específicos da síndrome PFAPA. Resultados: Após busca e seleção, foram incluídos 31 artigos. Avaliação e Diagnóstico: A síndrome PFAPA acomete principalmente crianças, sendo caracterizada por febre periódica acompanhada por faringite, estomatite aftosa e/ou adenite cervical. Seu diagnóstico é clínico e por exclusão, baseado em critérios estabelecidos. Recomendações: Os episódios costumam responder a prednisona e, em graus variáveis, a cimetidina e colchicina. Casos refratários e acompanhados de hipertrofia tonsilar são candidatos a tonsilectomia, devendo ser encaminhados à avaliação otorrinolaringológica.

Objective: To present information about the diagnosis and treatment of PFAPA syndrome in Primary Health Care. Methods: Systematic review of literature based on the PRISMA recommendation and carried out in the Scielo, Lilacs, Medline, IBECS and PubMed databases, including studies published from 2004 to 2018, in addition to consulting other PFAPA syndrome specific documents. Results: After search and selection, 31 articles were included. Assessment and Diagnosis: PFAPA syndrome affects mainly children and is characterized by periodic fever accompanied by pharyngitis, aphthous stomatitis and/or cervical adenitis. Its diagnosis is clinical and by exclusion, based on established criteria. Recommendations: The episodes usually respond to prednisone and, in varying levels, cimetidine and colchicine. Refractory cases and accompanied by tonsillar hypertrophy are candidates for tonsillectomy, and should be referred to otorhinolaryngological evaluation.

Objetivo: Presentar informaciones sobre el diagnóstico y tratamiento del síndrome PFAPA en la Atención Primaria a la Salud. Métodos: Revisión sistemática de literatura basada en la recomendación PRISMA y realizada en las bases de datos Scielo, Lilacs, Medline, IBECS y PubMed, incluyendo estudios publicados en el período 2004 a 2018, además de la consulta a otros documentos específicos del síndrome PFAPA. Resultados: Después de la búsqueda y selección, se incluyeron 31 artículos. Evaluación y Diagnóstico: El síndrome PFAPA acomete principalmente niños, siendo caracterizada por fiebre periódica acompañada por faringitis, estomatitis aftosa y/o adenitis cervical. Su diagnóstico es clínico y por exclusión, basado en criterios establecidos. Recomendaciones: Los episodios suelen responder a la prednisona y, en grados variables, a la cimetidina y colchicina. Los casos refractarios y acompañados de hipertrofia tonsilar son candidatos a tonsilectomía, debiendo ser encaminados a la evaluación otorrinolaringológica.

Long-term follow-up of tonsillectomy efficacy in children with PFAPA syndrome / Acompanhamento em longo prazo da eficácia da tonsilectomia em crianças com síndrome de PFAPA

Abstract Introduction: The role of tonsillectomy in the periodic fever, aphthous stomatitis, pharyngitis, and adenitis syndrome, is controversial. Although some studies reported high success rates with tonsillectomy, further investigations are needed with larger numbers of patients. Objective: To seek the long-term outcomes of tonsillectomy in periodic fever, aphthous stomatitis, pharyngitis, and adenitis syndrome. Methods: Case series; multi-center study. The study comprised 23 patients with periodic fever, aphthous stomatitis, pharyngitis, and adenitis syndrome who underwent surgery (tonsillectomy with or without adenoidectomy) between January 2009 and November 2014. Results: 21 (91%) of 23 patients had complete resolution immediately after surgery. One patient had an attack 24 h after surgery, but has had no further attacks. One patient had three attacks with various intervals, and complete remission was observed after 3 months. Conclusions: Tonsillectomy is a good option for the treatment of periodic fever, aphthous stomatitis, pharyngitis, and adenitis syndrome.

Resumo Introdução: O papel da tonsilectomia na síndrome da febre periódica, estomatite aftosa, faringite e adenite é controverso. Embora alguns estudos tenham relatado altas taxas de sucesso com a tonsilectomia, são necessárias mais pesquisas com um número maior de pacientes. Objetivo: Avaliar os resultados em longo prazo da tonsilectomia na síndrome de febre periódica, estomatite aftosa, faringite e adenite. Método: Série de casos; estudo multicêntrico. O estudo avaliou 23 pacientes com síndrome de febre periódica, estomatite aftosa, faringite e adenite submetidos a cirurgia (tonsilectomia com ou sem adenoidectomia) entre janeiro de 2009 e novembro de 2014. Resultados: Dos 23 pacientes, 21 (91%) apresentaram resolução completa imediatamente após a cirurgia. Um paciente apresentou um episódio 24 horas após a cirurgia, mas sem recorrência posterior. Um paciente teve três episódios com vários intervalos e a remissão completa foi observada após 3 meses. Conclusões: A tonsilectomia é uma boa opção para o tratamento da síndrome de febre periódica, estomatite aftosa, faringite e adenite.

Long-term follow-up of tonsillectomy efficacy in children with PFAPA syndrome.

INTRODUCTION: The role of tonsillectomy in the periodic fever, aphthous stomatitis, pharyngitis, and adenitis syndrome, is controversial. Although some studies reported high success rates with tonsillectomy, further investigations are needed with larger numbers of patients. OBJECTIVE: To seek the long-term outcomes of tonsillectomy in periodic fever, aphthous stomatitis, pharyngitis, and adenitis syndrome. METHODS: Case series; multi-center study. The study comprised 23 patients with periodic fever, aphthous stomatitis, pharyngitis, and adenitis syndrome who underwent surgery (tonsillectomy with or without adenoidectomy) between January 2009 and November 2014. RESULTS: 21 (91%) of 23 patients had complete resolution immediately after surgery. One patient had an attack 24h after surgery, but has had no further attacks. One patient had three attacks with various intervals, and complete remission was observed after 3 months. CONCLUSIONS: Tonsillectomy is a good option for the treatment of periodic fever, aphthous stomatitis, pharyngitis, and adenitis syndrome.

Aftas recurrentes en niños y adolescentes / Recurrent aphthous stomatitis in children and adolescents

La estomatitis aftosa recurrente es una patología que afecta la mucosa oral, se observa frecuentemente en niños y adolescentes. Objetivos: identificar las causas más frecuentes que coincidan con la aparición de aftas en niños y adolescentes, analizar si la alimentación presenta algún tipo de relación, evaluar la presencia de patologías sistémicas concomitantes y analizar el factor predisponente familiar. Material y método: Se realizó una encuesta de carácter anónimo en diferentes centros odontológicos públicos y privados de la ciudad de La Plata, a niños y adolescentes hasta 15 años de edad. Resultados: La población estudiada fueron niños y adolescentes hasta 15 años de edad. El 30 % manifestó sufrir aftas frecuentemente. El 91% de este grupo, lo asoció a situaciones de estrés (deporte competitivo y época de exámenes) y en menor medida a la época del año, período invernal. Afirmaron tener una dieta variada y consumir jugos artificiales con frecuencia. Se observó una alta incidencia de estomatitis aftosa recurrente en otros integrantes de la familia. Conclusión: La manifestación de estomatitis aftosa recurrente en la población estudiada coincide con situaciones de estrés. Se identificó un alto porcentaje de incidencia familiar, en padres, madres y hermanos (AU)

Recurrent aphthous stomatitis is a pathology which affects the oral mucosa and is frequently observed in children and adolescents. Purpose. To identify and analyze the most frequent factors which coincide with the development of aphthous stomatitis in children and adolescents. These factors include dietary habits, concomitant systemic diseases and family background as a predisposing factor. Materials and methods. An anonymous survey was conducted among children and adolescents in various public and private dental clinics from the city of La Plata. Results. The study population were children and adolescents up to 15 years. Thirty percent of patients reported a high frequency of ulcers. 91 % reported having ulcers under stressful situations (sports and exams) and to a lesser extent, during winter season. The patients claimed having a balanced diet and consuming artificial juices frequently. A high incidence of recurrent aphthous stomatitis was observed in other members of the family. Conclusion. The development of recurrent aphthous stomatitis in the studied population coincides with stressful situations. A high percentage of hereditary incidence was identified in parents and siblings (AU)

Recurrent aphthous ulceration: an epidemiological study of etiological factors, treatment and differential diagnosis

Abstract: BACKGROUND: Recurrent aphthous ulcerations are common benign ulcerated lesions on the mouth, whose etiology is poorly understood, with controversial treatment and difficult to control in clinical practice. OBJECTIVE: To evaluate the cases of recurrent aphthous ulcerations with a focus on treatment, diagnosis and etiology. METHODS: This is a retrospective study of the cases of the Oral Diagnosis service of the Rio Grande do Norte Federal University in Natal/RN. Data such as sex, age, race, location, smoking habits, types of treatment, relapsing episodes, laboratory test results and clinical characteristics were collected. The associations between the variables were analyzed using the Pearson Chi-square test (p <0.05). RESULTS: A total of 4895 patients were seen in the service over a period of 11 years. Of these, 161 (3.3%) had complaints of oral aphthous ulcerations, of which 76 (47.2%) were diagnosed as suffering from recurrent aphthous ulcerations and 68 (42.2%) with clinical information necessary for evaluation. The tongue was the most affected anatomical region, with 27 individuals (39.7%), followed by the buccal mucosa, with 22 cases (32.3%). STUDY LIMITATIONS: Retrospective study with data from medical records. CONCLUSION: Dental surgeons, dermatologists and otorhinolaryngologists are the main responsible for the first contact with patients with this disease and should be attentive to the clinical aspects and treat each patient in an individualized way, since the therapy is palliative, its diagnosis is by exclusion and its etiology is unknown.

A pilot study on the use of biolase in the treatment of recurrent aphthous ulcer

Recurrent Aphthous Ulcer (RAU) is a common oral pathology that produces pain which affects the lifestyle of the patient. Its aetiology and pathogenesis still remain unclear. A considerable number of treatments are available with the main goal directed towards pain relief. Previous studies on RAU treatment using low level laser therapy (LLLT) show immediate pain relief after application. Aim: This study aims to evaluate and compare treatment effectiveness in relieving pain provided by Waterlase (BIOLASE) LLLT and conventional topical corticosteroid using Triamcinolone Acetonide 0.1% dental paste. Methods: Thirty(30) volunteered patients of age between 18-27 years old weredivided into two groups. Each group consists of 15 patients with7 males and 8 females. Group 1 patients were treated by usingLLLT while group 2 patients were treated by using triamcinolone acetonide 0.1%. The patient's details, pain intensity and clinical photographs were recorded in a specially prepared case sheet.Mann-Whitney U test was used to compare significance in painreduction provided by both methods of treatment. Results:Both groups showed significant pain reduction immediately, day 3 and day 7. Higher reduction in pain intensity was observedimmediately (p=0.001) and 3 days (p=0.002) after treatment in group 1 patients (LLLT) compared to group 2 patients (triamcinolone acetonide 0.1%). Conclusion: Waterlase (BIOLASE) LLLT is clinically more effective in relieving pain compared to Triamcinolone Acetonide 0.1%

Recurrent aphthous stomatitis in 18-year-old adolescents - Prevalence and associated factors: a population-based study

Abstract: Background: Recurrent aphthous stomatitis is a painful disorder of unknown etiology. It is among the most common oral mucosal lesions with high prevalence among young adults. Objectives: To conduct a population-based study with 18-year-old army recruiters to assess its prevalence and associated factors in male adolescents. Methods: Interview during clinical examination in the army. Results: In this group (2,427 interviewed adolescents) there was a RAS prevalence of 24.9%. Smoking, herpes labialis and socioeconomic status correlated with the outcome. Study Limitations: only male adolescents were interviewed. Conclusions: Our results showed high prevalence of RAS; association with higher economic level and herpes simplex was found. Protective effect of smoking was confirmed.